Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.

MLA

Brunner, Andrew M., et al. “Haematopoietic Cell Transplantation with and without Sorafenib Maintenance for Patients with FLT3-ITD Acute Myeloid Leukaemia in First Complete Remission.” British Journal of Haematology, vol. 175, no. 3, Nov. 2016, pp. 496–504. EBSCOhost, https://doi.org/10.1111/bjh.14260.

APA

Brunner, A. M., Li, S., Fathi, A. T., Wadleigh, M., Ho, V. T., Collier, K., Connolly, C., Ballen, K. K., Cutler, C. S., Dey, B. R., El-Jawahri, A., Nikiforow, S., McAfee, S. L., Koreth, J., Deangelo, D. J., Alyea, E. P., Antin, J. H., Spitzer, T. R., Stone, R. M., … Chen, Y.-B. (2016). Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission. British Journal of Haematology, 175(3), 496–504. https://doi.org/10.1111/bjh.14260

Chicago

Brunner, Andrew M, Shuli Li, Amir T Fathi, Martha Wadleigh, Vincent T Ho, Kerry Collier, Christine Connolly, et al. 2016. “Haematopoietic Cell Transplantation with and without Sorafenib Maintenance for Patients with FLT3-ITD Acute Myeloid Leukaemia in First Complete Remission.” British Journal of Haematology 175 (3): 496–504. doi:10.1111/bjh.14260.